AGTX
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
1.26M
SKYE
Price
$4.13
Change
+$0.14 (+3.50%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
127.67M
Interact to see
Advertisement

AGTX vs SKYE

Header iconAGTX vs SKYE Comparison
Open Charts AGTX vs SKYEBanner chart's image
Agentix
Price$0.03
Change-$0.00 (-0.00%)
Volume$185.23K
Capitalization1.26M
Skye Bioscience
Price$4.13
Change+$0.14 (+3.50%)
Volume$5.58K
Capitalization127.67M
AGTX vs SKYE Comparison Chart in %
Loading...
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGTX vs. SKYE commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGTX is a Hold and SKYE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (AGTX: $0.03 vs. SKYE: $4.00)
Brand notoriety: AGTX and SKYE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGTX: 1481% vs. SKYE: 142%
Market capitalization -- AGTX: $1.26M vs. SKYE: $127.67M
AGTX [@Biotechnology] is valued at $1.26M. SKYE’s [@Biotechnology] market capitalization is $127.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGTX’s FA Score shows that 1 FA rating(s) are green whileSKYE’s FA Score has 0 green FA rating(s).

  • AGTX’s FA Score: 1 green, 4 red.
  • SKYE’s FA Score: 0 green, 5 red.
According to our system of comparison, both AGTX and SKYE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGTX’s TA Score shows that 6 TA indicator(s) are bullish while SKYE’s TA Score has 4 bullish TA indicator(s).

  • AGTX’s TA Score: 6 bullish, 3 bearish.
  • SKYE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AGTX is a better buy in the short-term than SKYE.

Price Growth

AGTX (@Biotechnology) experienced а +0.32% price change this week, while SKYE (@Biotechnology) price change was +14.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was +11.00%, and the average quarterly price growth was +33.00%.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SKYE($128M) has a higher market cap than AGTX($1.27M). SKYE YTD gains are higher at: 41.343 vs. AGTX (-82.213). AGTX has higher annual earnings (EBITDA): -545.9K vs. SKYE (-41.68M). SKYE has more cash in the bank: 48.6M vs. AGTX (4.41K). AGTX has less debt than SKYE: AGTX (343K) vs SKYE (368K). AGTX (0) and SKYE (0) have equivalent revenues.
AGTXSKYEAGTX / SKYE
Capitalization1.27M128M1%
EBITDA-545.9K-41.68M1%
Gain YTD-82.21341.343-199%
P/E RatioN/A3.57-
Revenue00-
Total Cash4.41K48.6M0%
Total Debt343K368K93%
FUNDAMENTALS RATINGS
AGTX vs SKYE: Fundamental Ratings
AGTX
SKYE
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4241
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGTX's Valuation (4) in the null industry is somewhat better than the same rating for SKYE (39). This means that AGTX’s stock grew somewhat faster than SKYE’s over the last 12 months.

AGTX's Profit vs Risk Rating (100) in the null industry is in the same range as SKYE (100). This means that AGTX’s stock grew similarly to SKYE’s over the last 12 months.

SKYE's SMR Rating (98) in the null industry is in the same range as AGTX (100). This means that SKYE’s stock grew similarly to AGTX’s over the last 12 months.

SKYE's Price Growth Rating (41) in the null industry is in the same range as AGTX (42). This means that SKYE’s stock grew similarly to AGTX’s over the last 12 months.

SKYE's P/E Growth Rating (97) in the null industry is in the same range as AGTX (100). This means that SKYE’s stock grew similarly to AGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGTXSKYE
RSI
ODDS (%)
Bearish Trend 4 days ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
67%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GCTS1.330.01
+0.76%
GCT Semiconductor Holding
VTAK2.480.01
+0.40%
Catheter Precision Inc
BOC13.50N/A
N/A
Boston Omaha Corp
DRS41.07-0.13
-0.32%
Leonardo DRS
OFG44.35-0.45
-1.00%
OFG Bancorp

AGTX and

Correlation & Price change

A.I.dvisor tells us that AGTX and RLAY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGTX and RLAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGTX
1D Price
Change %
AGTX100%
+1.50%
RLAY - AGTX
32%
Poorly correlated
-1.33%
RVMD - AGTX
28%
Poorly correlated
+1.38%
SKYE - AGTX
23%
Poorly correlated
+3.00%
ALGS - AGTX
23%
Poorly correlated
-2.03%
BCYC - AGTX
22%
Poorly correlated
-1.68%
More

SKYE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SKYE has been loosely correlated with CRBP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SKYE jumps, then CRBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SKYE
1D Price
Change %
SKYE100%
+6.67%
CRBP - SKYE
48%
Loosely correlated
-1.60%
JANX - SKYE
40%
Loosely correlated
+0.17%
VKTX - SKYE
34%
Loosely correlated
+1.70%
NKTR - SKYE
32%
Poorly correlated
+11.67%
ABOS - SKYE
32%
Poorly correlated
+4.35%
More